Search

everythinglearnresearchcommunity

for

Search:↓

Childhood and adult height, and early immune-related hospitalizations increase testicular cancer risk, while baldness, larger families, and sports reduce it.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Finasteride is effective for treating BPH but not recommended for prostate cancer prevention.

Androgen-driven traits don't predict prostate cancer recurrence.

5-ARI therapy may help prevent prostate cancer progression.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

A rare scalp tumor was removed from a 49-year-old woman, with a good outlook if benign but needing careful monitoring if malignant.

Early detection and complete surgical removal are crucial for better outcomes in treating pilomatrix carcinoma.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Further research is needed to develop effective cancer prevention strategies.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

The meeting highlighted advances in sexual medicine and priapism management.

Finasteride can't be recommended for cancer prevention due to concerns about high-grade cancer risk.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Finasteride may help treat recurrent priapism in sickle cell anemia.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

A benign skin tumor grew quickly in a dialysis patient and was surgically removed.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

There is no strong evidence that chemopreventive agents effectively prevent prostate cancer.

Men with better urinary symptoms have a lower risk of death.

HIV-positive men who have sex with men have a higher rate of anal beta-papillomavirus infections.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.